• PIN49 Vaccination Rates Among the General Adult Population and High-Risk Groups in EU, US, JAPAN, South Korea and Taiwan

    Sep 1, 2020, 00:00

  • PMD3 A Budget IMPACT Analysis of Implementing Safety Needles for Venous Blood Collection in China

    Sep 1, 2020, 00:00

  • PRS7 Health Economic Analysis to Evaluate the Economic and Humanistic IMPACT of LEVEL I Versus LEVEL III Diagnosis of Obstructive SLEEP Apnea in India Among Adults

    Sep 1, 2020, 00:00

  • PMD15 Cost Utility Analysis of New Matrix Therapy Regenerating Agent (RGTA®) VS Good Wound Care for Patients with Advanced Diabetic Foot Ulcer

    Sep 1, 2020, 00:00

  • PNS26 Real-World Evidence in Regulatory Decision-Making: Parallel between FDA in the US and Pmda in JAPAN

    Sep 1, 2020, 00:00

  • PCN27 Study of Initial Treatment Cost for ACUTE Leukemia Patients in Vietnam

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PMD10 Cost-Utility Analysis of Robotic-Assisted Surgery for Prostate Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PNS59 Reliability and Validity of the SF-12V2 Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population

    Sep 1, 2020, 00:00

  • PCN9 Bayesian Network Meta-Analyses of the Efficacy of LONG-Acting Release Somatostatin Analogs in Patients with Advanced Neuroendocrine Tumors: Application of Different Parametric and Fractional Polynomial Methods

    Sep 1, 2020, 00:00

  • PDB10 Cost-Effectiveness of Canagliflozin Versus Sitagliptin in Chinese Patients with Type 2 Diabetes on Background Metformin Monotherapy

    Sep 1, 2020, 00:00

  • PBI1 Comparison of the Combination of Recombinant Follicle-Stimulating Hormone and Recombinant Luteinizing Hormone Protocol Versus Human Menopausal Gonadotropin Protocol in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analys ...

    Sep 1, 2020, 00:00

  • PMU5 Costs and Health Outcomes of Korean Children Attributable to Secondhand Smoke Exposure at HOME: An Analysis By a Markov MODEL

    Sep 1, 2020, 00:00

  • PSY1 Medication Trends and Medical Costs Among Patients with Rheumatoid Arthritis on Biologics Treatment in Taiwan: A 6-Year Cohort Study Using a National Claims Database

    Sep 1, 2020, 00:00

  • PIH10 Estimating Economic Burden of CHILD Asthma Attributing to Exposure to PM2.5 in JAPAN

    Sep 1, 2020, 00:00

  • PRS18 The IMPACT of Idiopathic Pulmonary Fibrosis on Health State Utility Values: Evidence from Australia

    Sep 1, 2020, 00:00

  • PRS11 Comparison of Health-Related Quality of Life for Adult Patients with Asthma in ASIA and the U.S

    Sep 1, 2020, 00:00

  • PRS19 Use of Patient Reported Outcomes in Asthma Product Development in JAPAN: A Review of Labeled Products

    Sep 1, 2020, 00:00

  • PCN87 Key Clinical and Economic Rationales for Oncology Reviews in South Korea

    Sep 1, 2020, 00:00

  • PRO6 Epidemiology and Treatment Patterns of Hemophilia a in Taiwan from 2013 to 2017

    Sep 1, 2020, 00:00

  • PIN54 Association of Maternal Hbsag and Hbeag Serostatus and Congenital Abnormalities Following Assisted Reproduction: A Population-Based Study

    Sep 1, 2020, 00:00

  • PCV18 Risk Prediction Models for in-Hospital Mortality in ACUTE Aortic Dissection: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS52 Valuating Pharmaceutical Innovations Beyond Qalys: A Comprehensive Analysis of VALUE-Based Pricing Models

    Sep 1, 2020, 00:00

  • PIH11 Falls Risk Increasing Drugs in the Elderly: Population Based Study Using Korean National Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PDB17 Time to Onset Analysis of Ipilimumab Associated Hypophysitis Using DATA from FDA Adverse Event Reporting System (FAERS) Database

    Sep 1, 2020, 00:00

  • PDB25 Long-Term Drug Survival and Low Remission Rates in Dyslipidemia Patients Having Drug Safety Concerned and Safety Literacy

    Sep 1, 2020, 00:00

  • PIN51 Out-of-Pocket Healthcare Expenditure in Various Household Income Groups Among Patients with Hepatitis C Disease Stages: Findings from a Tertiary Care Centre in Malaysia

    Sep 1, 2020, 00:00

  • PBI5 Future Trends on the Biosimilar Uptake in China, JAPAN, the US, the EU4 and the UK

    Sep 1, 2020, 00:00

  • PBI2 Economic Evaluation of GENE Therapies: IMPACT of Alternative Payment Models on Uncertainty Around the Icer

    Sep 1, 2020, 00:00

  • PSU6 A Patient-LEVEL Simulation for Economic Evaluation of Vascular Service Reconfiguration in England

    Sep 1, 2020, 00:00

  • PDB29 Diagnostic and Prognostic VALUE of Galectin-3 and GDF-15 in Diabetic Nephropathy Patients

    Sep 1, 2020, 00:00

  • Knowledge and Attitude of Physicians Towards the Cost of Commonly Prescribed Medicines: A Case Study in Three Nigerian Healthcare Facilities

    Sep 1, 2020, 00:00

  • PIN14 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 65 YEARS and Older in Korea

    Sep 1, 2020, 00:00

  • PCN22 Cost-Effectiveness of Pembrolizumab PLUS Axitinib Versus Nivolumab PLUS Ipilimumab As First-LINE Treatment of Advanced Renal CELL Carcinoma

    Sep 1, 2020, 00:00

  • PCN81 The Role of Different Specialties in the Management of NON-SMALL CELL LUNG Cancer: Insights from a Real-World Study

    Sep 1, 2020, 00:00

  • PIH12 COMPARISON OF THE POST-MARKET UTILIZATION PATTERNS OF ALZHEIMER'S DISEASE TREATMENTS BETWEEN SOUTH KOREA AND AUSTRALIA: TIME TO CONSIDER REASSESSMENT OF COST-EFFECTIVENESS

    Sep 1, 2020, 00:00

  • PCV17 Systematic Literature Review of Cardiovascular Risk Factor Management in 11 Asian Markets

    Sep 1, 2020, 00:00

  • PCN61 Frequency of Myalgia in Patients with Gynecological Cancer

    Sep 1, 2020, 00:00

  • PCV27 Assessment of Health Related Quality of Life Among Adherent and NON-Adherent Medication Group of Coronary Artery Disease Patients

    Sep 1, 2020, 00:00

  • PRO10 Income LEVEL Shift of RARE Disease Patients in South Korea

    Sep 1, 2020, 00:00

  • PSU11 Trends in the Adoption of Minimally Invasive Partial Nephrectomy in South Korea

    Sep 1, 2020, 00:00

  • PND2 A Meta-Analysis of Efficacy and Safety of Vesicular Monoamine Transporter Type 2 Inhibitors for Treatment of Huntington Chorea

    Sep 1, 2020, 00:00

  • PND22 Application of Therapeutic Plasma Exchange in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PDG19 Status of Published Pharmacoeconomic Evidence on Monoclonal Antibodies Reimbursed in China

    Sep 1, 2020, 00:00

  • The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia

    Sep 1, 2020, 00:00

  • PNS2 Voice Technology - an Opportunity to Broaden Participation in Patient Reported Outcomes Research

    Sep 1, 2020, 00:00

  • PDB20 Clinical Outcomes Among Patients with Hyperkalemia in China: A Population-Based Retrospective Study

    Sep 1, 2020, 00:00

  • PMU13 Defining the ROLL out Strategy for UHC Benefits: Philhealth's Benefit Development PLAN

    Sep 1, 2020, 00:00

  • PMH1 MODEL Based Pharmacoeconomic Evaluation of Medication for Depression Disorder: A Systematic Review

    Sep 1, 2020, 00:00

  • PMS1 Economic Outcomes of Ankylosing Spondylitis Patients Initiating Biologic Therapy in Taiwan - a Population-Based Analysis

    Sep 1, 2020, 00:00

  • PCN5 Real-World Incidence and Management of Adverse Events (AE) in Patients with NON-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide

    Sep 1, 2020, 00:00

  • PCN55 A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma (HCC) Screening Strategies

    Sep 1, 2020, 00:00

  • PRS16 Development of an Accurate Operational Definition for Asthma Using Logistic Regression MODEL

    Sep 1, 2020, 00:00

  • PNS63 A Cross-Sectional Study About Medications Wastage In Saudi Arabia

    Sep 1, 2020, 00:00

  • Editorial Board

    Sep 1, 2020, 00:00

  • PIN41 Economic Burden of 2009 Pandemic H1N1 Influenza in Mainland China: A Systematic Review and Modelling Study

    Sep 1, 2020, 00:00

  • PBI7 Comparison of Biosimilar Policies between Key Countries in ASIA, EU and USA

    Sep 1, 2020, 00:00

  • PDG22 Comparison of Healthcare Systems and Opportunities for Innovative Drugs across India, Vietnam, and Indonesia

    Sep 1, 2020, 00:00

  • PCN73 Is Time to Access Novel Cancer Therapies in Asia Accelerating? A Preliminary Investigation

    Sep 1, 2020, 00:00

  • PND12 Vagus Nerve Stimulation Versus ANTI-Epileptic Drug in Chinese Patients with Drug-Resistant Epilepsy: A Cost–Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PNS65 Comparison of Quality of Life and Burden of Lower Back PAIN Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

    Sep 1, 2020, 00:00

  • PDG14 Evaluating Accessibility of Essential Medicines in Indonesia: A Survey on Availability and Price in Public and Private Health Sectors

    Sep 1, 2020, 00:00

  • PCV4 Review On:-Cardiovascular Risk Reduction With Icosapent Ethyl For Hypertriglyceridemia

    Sep 1, 2020, 00:00

  • PMH13 Children with Computer GAME Addiction Benefit from Visuospatial Training

    Sep 1, 2020, 00:00

  • PCN50 Disease Burden of Chronic Myeloid Leukemia UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PAM1 Efficacy and Safety of Prebiotics, Probiotics and Synbiotics for Treatment or Prevention of Asthma: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN107 Real World Chart Review of Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib in Korea

    Sep 1, 2020, 00:00

  • PNS55 The Effect of Pharmaceutical Policy on Demand for Branded Medicines: A Discrete Choice Experiment from Australia

    Sep 1, 2020, 00:00

  • PCN18 A Budget IMPACT Analysis of Fixed Dose Combination of Netupitant and Palonosetron (NEPA) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Malaysia

    Sep 1, 2020, 00:00

  • PSU1 Real-World Cost-Effectiveness Analysis of Minimal Invasive PLATE Osteosynthesis (MIPO) Versus Conventional OPEN Reduction Internal Fixation of Proximal Humeral Fracture (PHF)

    Sep 1, 2020, 00:00

  • PSU9 The Cost Analysis of Patients Undergoing TOTAL Knee Arthroplasty in China

    Sep 1, 2020, 00:00

  • PDB23 Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disorder: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PDB5 Assesment the Quality of Life in Children with Type 1 Diabetes

    Sep 1, 2020, 00:00

  • PCN72 APAC Overview of the Accelerated Approval Pathways: Applications in LUNG Cancer

    Sep 1, 2020, 00:00

  • PDB30 Digital Medication Health Service Platforms of Pharmaceutical Companies for Type 2 Diabetes Mellitus (T2DM) Patients: A Content Analysis of Application

    Sep 1, 2020, 00:00

  • PCV16 Increasing Burden of Cardiovascular Disease (CVD), the Associated Risk Factors and Drug Utilization Among Smokers in the US: A Study Based on Nhanes from 2005 to 2016

    Sep 1, 2020, 00:00

  • PCN64 Frequency of ORAL Mucositis in Male Patients Receiving Cancer Therapy

    Sep 1, 2020, 00:00

  • PDG10 An Economic Evaluation of Tofacitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis in Singapore

    Sep 1, 2020, 00:00

  • PDB28 A Real-World Effectiveness of Udca Added to Oha on Glycemic Control in Type 2 Diabetes Patients with LIVER Disease

    Sep 1, 2020, 00:00

  • PMH9 Comparison of Approved Doses of Lemborexant for Insomnia in Placebo-Controlled Trials: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PSS5 Disease Burden of Rvo-ME in China——a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PCN51 Disease Burden of Mantle CELL Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PDB16 Identifying Prevalence and Risk Factors of Poor Glycemic Control Among Diabetic Patients in a Central RURAL Province of Saudi Arabia

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PDG4 Cost-Utilities Analysis of First LINE Treatments on Advanced STAGE EGFR Positive in NON-SMALL CELL LUNG Cancer Patients in Taiwan

    Sep 1, 2020, 00:00

  • PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries

    Sep 1, 2020, 00:00

  • PCV29 Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions

    Sep 1, 2020, 00:00

  • PMH8 A DEEP Learning Approach for Predicting Onset of Depressive Disorder Using Health Insurance Claims DATA

    Sep 1, 2020, 00:00

  • PCN78 Cost Comparison of Administering ORAL Compared to Intravenous paclitaxel for Patients with Advanced Gastric Cancer in South Korea: A MICRO-Costing Study

    Sep 1, 2020, 00:00

  • PRO11 Policy Initiatives to Facilitate the Patient Access to Orphan Drugs in China

    Sep 1, 2020, 00:00

  • PNS3 Managed Entry Agreements: The European Experience and the Potential in JAPAN

    Sep 1, 2020, 00:00

  • PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

    Sep 1, 2020, 00:00

  • PCV28 The EQ-5D-5L Is More Discriminative Than The EQ-5D-3L In Patients With Cardiovascular Diseases: A Multi-Ethnic Asian Study

    Sep 1, 2020, 00:00

  • PRS10 Impact of Tobacco Smoking before Pregnancy on Quality of Life of Pregnant Women: A National Cross-Sectional Study

    Sep 1, 2020, 00:00

  • PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

    Sep 1, 2020, 00:00

  • PNS40 The Implementation of Volume-Based Drug Procurement Policy in China

    Sep 1, 2020, 00:00

  • PSU12 Landscape Analysis of Analgesics Utilization during Perioperative Period in China

    Sep 1, 2020, 00:00

  • PND21 BUDGET IMPACT OF ROTIGOTINE ON CHINESE NATIONAL MEDICAL FUND PAYMENT FOR PARKINSON'S DISEASE

    Sep 1, 2020, 00:00

  • PUK7 Budget Impact Of A New Mobile Application Reimbursement Strategy For Diabetic Patients In Andhra Pradesh (India)

    Sep 1, 2020, 00:00

  • PND10 Assessing the Cost of Treatment for Myasthenia Gravis Crisis Patients in Australia

    Sep 1, 2020, 00:00

  • PAM2 Cost-Effectiveness of Thread Embedding Therapyfor Patients with Chronic, Herniated Lumbar Disk

    Sep 1, 2020, 00:00

  • PDB15 Cost-Effectiveness of Gliclazide MR-Based Intensive Glucose Control Versus Standard Glucose Control in Type 2 Diabetes Mellitus: Pharmacoeconomic Analysis in Thailand Based on the Advance Trial MODEL

    Sep 1, 2020, 00:00

  • PIH6 Economic Evaluation of the Automated Resuscitator Device for Asphyxiated Neonates in Tertiary LEVEL Healthcare Setting in India

    Sep 1, 2020, 00:00

  • Prioritization of Medicine Importation by the Private Sector in Sudan: Evidence from a Data Analysis, 2012-2015

    Sep 1, 2020, 00:00

  • PCN3 Knowledge of Treatment Assignment and Clinician Adverse Event Reporting: An Evaluation in Multiple Myeloma

    Sep 1, 2020, 00:00

  • PNS43 Economic Evaluation of a Community-Based Maternal and CHILD Health Service in JAPAN

    Sep 1, 2020, 00:00

  • PMS9 Expected Benefits over the Next 20 Years of Osteoporotic Secondary Fracture Prevention Policies Amongst Women in Thailand

    Sep 1, 2020, 00:00

  • PNS28 Recent Japanese Generic Drug Policy and Future Directions

    Sep 1, 2020, 00:00

  • PMU16 Assessing Health Technologies in EARLY Detection of Primary Immunodeficiency Diseases: A Case Study of Evidence-Based VALUE Framework in RARE Diseases

    Sep 1, 2020, 00:00

  • PMD12 Key Considerations of VALUE Assessment Frameworks for Medical Devices and Diagnostics in ASIA Pacific

    Sep 1, 2020, 00:00

  • PND25 Identification of NOVEL Drug Targets and Exploring Drug Repurposing Avenues for Amyotrophic Lateral Sclerosis

    Sep 1, 2020, 00:00

  • PND3 Patient-Reported Outcomes Following Neuromanual Therapy For Carpal Tunnel Syndrome- Comparison Of Four Patient Healthcare Outcome Measures In A Randomized Clinical Trial

    Sep 1, 2020, 00:00

  • PNS54 Competencies Required in the Profile of the Health Professional for Management and Assistance in Telemedicine Programs: A Review of the Literature

    Sep 1, 2020, 00:00

  • PNS36 Cost-Benefit Analysis of Dental Prevention Programs for Children in Taiwan

    Sep 1, 2020, 00:00

  • PUK2 Assessing Mortality Risk and Renal Outcomes in Chronic Kidney Disease Patients Treated with Sglt-2 Inhibitors or DPP-4 Inhibitors: A Real-World Study

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PCN35 Out-of-Pocket Cost of Cancer Treatement: A Systematic Review for Literatures from Taiwan

    Sep 1, 2020, 00:00

  • PRS2 Impact Of Knowledge And Attitude On Antibiotic Used For Upperrespiratory Tract Infections At Burapha University 2019

    Sep 1, 2020, 00:00

  • PMH11 Post Partum Depression:Prevalence, Risk Factors/Causes, Knowledge and Medication Use

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PRO1 The Market Access Landscape for Orphan Drugs in APAC: A Comparison of Policies in FIVE Major Markets

    Sep 1, 2020, 00:00

  • PIH4 Preoperative Skin Preparation for Caesarean Deliveries in Australian Public Hospitals: Surgical Site Infecton and Cost Outcomes Associated with Using Alcoholic Chlorhexidine Gluconate Applicator Versus Bulk Aqueous Povidone Iodine Solu ...

    Sep 1, 2020, 00:00

  • PDB1 Telemedicine Use for Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

    Sep 1, 2020, 00:00

  • PND26 Biological Activity of Ascaridole through Interference of Binding Sites of Topoisomerase I, Topoisomerase II, Acetylcholinesterase, SOD and Catalase for the Treatment of Alzheimer's Disorders

    Sep 1, 2020, 00:00

  • PIN23 Systematic Review of Economic Evaluations of Pneumococcal Conjugate Vaccines in Mainland China

    Sep 1, 2020, 00:00

  • PRS12 Prospective Association between LUNG Function and the Incidence of Diabetes, Asthma, Myocardial Infarction, Hypertension and ALL-Cause Mortality: Competing Risks MODEL

    Sep 1, 2020, 00:00

  • PNS21 Drug Pricing System Reform and the Formal Introduction of Health Technology Assessment in JAPAN

    Sep 1, 2020, 00:00

  • PCV21 Association between Low-Income Status and Death in Japanese Patients with Heart Failure: Life Study

    Sep 1, 2020, 00:00

  • PNS71 ACCESSING MULTIPLE PATIENT DATA SOURCES TO ENHANCE GENERATION OF REAL-WORLD EVIDENCE, OUTCOME RESEARCH AND NON-RESEARCH EVALUATIONS

    Sep 1, 2020, 00:00

  • PIN17 A Systematic Literature Review of the Disease and Economic Burden of Multidrug Resistance Gram Negative Infections (MRGN) in JAPAN

    Sep 1, 2020, 00:00

  • PDG6 A Cost/Cost-Utility Analysis of Cefaclor Hypersensitivity in South Korea

    Sep 1, 2020, 00:00

  • PIN32 Disease Burden of Hepatitis C Infection Among the General Population in ASIA: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN65 Disease and Economic Burden of Cancer Associated Thrombosis Among SOLID Tumour Malignancy in Malaysia

    Sep 1, 2020, 00:00

  • PRS8 The Cost Effectiveness Analysis of SIX COPD Treatment Strategies in China

    Sep 1, 2020, 00:00

  • PCN70 Budget Savings from Patent Expiration of Cancer Drugs in South Korea

    Sep 1, 2020, 00:00

  • Valuing Health State: An EQ-5D-5L Value Set for Ethiopians [Editor's Choice]

    Sep 1, 2020, 00:00

  • PNS7 A Systematic Review of Cost Utility Studies Conducted from an Indian Perspective

    Sep 1, 2020, 00:00

  • PRO14 Quality of Life in Patients with Gaucher Disease and Factors Associated: A Study on Adult Patients in China

    Sep 1, 2020, 00:00

  • PIN19 Direct Medical Cost of HIV/AIDS Treatment in Vietnam

    Sep 1, 2020, 00:00

  • PRS13 Market Access of Asthma and COPD Medications As a Tool to Increase Drugs Availability in Russian Federation

    Sep 1, 2020, 00:00

  • PCN41 Cost-Effectiveness of Pembrolizumab in Combination with Chemotherapy in the 1ST LINE Treatment of Metastatic NSCLC in Taiwan

    Sep 1, 2020, 00:00

  • PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PAM5 Cost-Effectiveness Analysis of Lusutrombopag for the Treatment of Thrombocytopenia in Chronic LIVER Disease Patients PRIOR to an Elective Invasive Procedure in JAPAN

    Sep 1, 2020, 00:00

  • PMD5 Evaluation of Cost Analysis of the Midline Catheter Versus Peripherally Inserted Central Catheter in Korea in the Inpatient Setting

    Sep 1, 2020, 00:00

  • PND9 Effects and Cost of Gastrodin Injection on Dizziness and Vertigo: A Propensity Score-Matched Cohort Study Based on Real-World DATA

    Sep 1, 2020, 00:00

  • PRO12 Investigation of Consistency of Haemophilia a Care in JAPAN: A Claims-Based Cohort Study

    Sep 1, 2020, 00:00

  • PMD8 Mortality after Use of paclitaxel-Based Devices in Peripheral Arteries : A Real-World Analysis

    Sep 1, 2020, 00:00

  • PIH16 Use of Tripod Checklist to Evaluate the Reporting Quality of Prognostic Prediction Models for Obstetric Care

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PIN7 The Cost Effectiveness Analysis of a Nonavalent Vaccine in China

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PCN2 The Effect of IMAGE-Guided Radiotherapy on Cancer Patients' Survival

    Sep 1, 2020, 00:00

  • PSU15 A Cost Analysis of OPEN, Laparoscopic and ROBOT-Assisted Hysterectomy for Endometrial Cancer in Korea

    Sep 1, 2020, 00:00

  • PDB22 Drug Related Problems in Type-2-Diabetes Mellitus with and without Cardiovascular Diseases: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIH9 Quantification Of Sleep Quality Among Older Adults In The State Of Penang, Malaysia

    Sep 1, 2020, 00:00

  • PNS32 Impoverishing Effects Of Out-Of-Pocket Health Expenditures In India

    Sep 1, 2020, 00:00

  • PUK6 Assessing Trend In Medical Expenditure And Measuring The Impact Of Health-Related Quality Of Life (HRQOL) On Medical Expenditure For U.S. Adults With Diabetes Associated Chronic Kidney Disease (CKD)Using 2002-2016 Medical Expenditure P ...

    Sep 1, 2020, 00:00

  • PDB14 Cost-Effectiveness of Liraglutide Versus Exenatide, BOTH in Combination with Metformin for Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PMH12 Trends in Use of Prescription, over the Counter, and Traditional Chinese Medicine for Mental Health Conditions in China, 2009 - 2017

    Sep 1, 2020, 00:00

  • PDG8 The Cost-Effectiveness of Direct-Acting Antivirals Coverage Policies for Patients with Hepatitis C VIRUS Infection in Taiwan

    Sep 1, 2020, 00:00

  • PRO9 Orphan Drug Pricing in JAPAN Since Reform

    Sep 1, 2020, 00:00

  • PCN14 Disease Burden of Waldenstrom's Macroglobulinemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PSS3 Bioinformatics Analysis of Potential Targets for Drug Repurposing in Contact Eczema through Microarray Profiles

    Sep 1, 2020, 00:00

  • PCN47 Disease Burden of Gastric Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMU24 Using the Medication Adherence Reasons Scale (MAR-SCALE) to Identify the Reasons for Medication NON-Adherence Among Type 2 Diabetes, Migraine, and Depression Medication Users in JAPAN

    Sep 1, 2020, 00:00

  • PCN62 Investigation of Diseases Incidence after Administration of Immune Check Inhibitors in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PIN33 Public Health Behaviour Changes during the Covid-19 Outbreak in China: A Comparison in Different Risk Groups

    Sep 1, 2020, 00:00

  • PND28 Children with Hypoxic-Ischaemic Encephalopathy Have a Delay in the Development of Executive Abilities

    Sep 1, 2020, 00:00

  • PCN7 Adverse Events (AES) of Advanced Renal CELL Carcinoma (RCC) Patients Treated with Targeted Therapies in Real World Setting in Korea

    Sep 1, 2020, 00:00

  • PCN25 Hospital Costs Associated with Powered and Manual Staplers in VIDEO-Assisted Thoracic Surgery Lobectomy for LUNG Cancer in a Chinese Teritary Care Hospital

    Sep 1, 2020, 00:00

  • PIN40 Influenza Vaccination in Adult Patients with Hypertension or Diabetes in South Korea: A CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PRS9 Economic Burden of Adult Patients with Asthma Using a CROSS-Sectional Analysis of Survey DATA in ASIA and the U.S

    Sep 1, 2020, 00:00

  • PNS67 The Humanistic Burden of Caregiving in China, Japan, and the US

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PNS29 IMPACT of Pharmacoeconomic Evaluation Guidelines: A Systematic Review of Reporting Quality of Pharmacoeconomic Evaluations for NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PIN8 Analysis of Potential Cost-Savings after Introduction of 0.1% Polihexanide/Betaine Solution for Chronic Wounds in Reimbursement Healthcare System of Korea

    Sep 1, 2020, 00:00

  • PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

    Sep 1, 2020, 00:00

  • PND14 Identifying Patients with RARE Refractory Epilepsies in Japanese Health Databases: Feasibility for a Burden of Illness Study

    Sep 1, 2020, 00:00

  • PMS17 Usability Testing of a Patient Engagement Digital Platform for TOTAL Knee Arthroplasty (TKA) Patients in JAPAN

    Sep 1, 2020, 00:00

  • PIN35 Evaluation of Effectiveness of Knowledge Transfer of Antimicrobial Resistance to Hong Kong Elderly: A Quasi-Experiment

    Sep 1, 2020, 00:00

  • PGI2 Quantitative Evaluation to Efficacy and Safety of Biosimilar of Infliximab in Inflammatory Bowel Diseases: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PND19 Economic and Social Factors Affecting Healthcare Expenditure for Households with Cerebrovascular Diseases

    Sep 1, 2020, 00:00

  • PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Databas ...

    Sep 1, 2020, 00:00

  • PMU14 China's 2019 National Reimbursement Drug LIST Update: Implications on Global and Local Manufacturer Strategy

    Sep 1, 2020, 00:00

  • PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PNS31 Increased Cigarette Taxes and Quitting Behavior Among Adults

    Sep 1, 2020, 00:00

  • PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PNS64 Landscape Analysis of Studies in Asia Eliciting Patient Preferences for Therapeutic Interventions

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »